Measuring Impact in Medical Affairs Summit

The Measuring Impact in Medical Affairs Summit is uniting Medical Affairs leaders from across pharma and biotech to define, benchmark, and standardize meaningful KPIs that capture the true value of Medical Affairs activities.

As Medical Affairs cements its role as the strategic bridge between R&D and commercialization, the pressure to quantify and communicate impact has never been greater. In an era of tighter budgets, digital transformation, and AI-driven analytics, teams must move beyond activity tracking to demonstrate measurable outcomes that drive scientific, stakeholder, and commercial success.

This year, join 50+ experts from Boehringer Ingelheim, Abbvie, Alexion, Travere, Regeneron, and more to explore how leading teams are designing metrics that reflect quality over quantity, leveraging AI to enhance insight generation, and co-creating the next generation of KPIs defining Medical Affairs excellence. Don’t miss the only meeting dedicated to transforming Medical Affairs from an activity-based to an impact-driven function.

Find out more: https://ter.li/ymwe2l